BREAK IN TRANSCRIPT
Mr. OBERNOLTE. Mr. Speaker, I thank my friend, the gentleman from Georgia, for recognizing me.
Mr. Speaker, I rise in strong support as both a member of the Health Subcommittee and a proud cosponsor of this bill, H.R. 1262, the Give Kids a Chance Act.
Mr. Speaker, we live in the most technologically advanced society in the history of human civilization, and modern medicine has recently come up with amazing solutions and cures for many of the physical ailments that have afflicted humanity.
Unfortunately, Mr. Speaker, we have many rare pediatric diseases for which there is no cure. While we are researching the cures for those diseases, thousands and thousands of children continue to suffer.
Mr. Speaker, we need to give every priority and do everything we possibly can to speed up the delivery of these treatments for rare pediatric diseases, and that is what this bill is all about. The Give Kids a Chance Act will reauthorize the FDA's Priority Review Voucher system to speed the research and development of these technologies and innovative treatments and bring them to market. It also clarifies the FDA's authority over expediting these therapies and reauthorizes needed funding for the NIH to fund research and development into these cures.
Mr. Speaker, this bill will help us finally bring solutions to these thousands of suffering children.
Mr. Speaker, I thank my bipartisan cosponsors for their hard work on this bill. I urge this body to pass it this evening and urge its speedy consideration in the Senate.
BREAK IN TRANSCRIPT